Literature DB >> 8913729

Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma.

L F Hu1, G Eiriksdottir, T Lebedeva, I Kholodniouk, A Alimov, F Chen, Y Luo, E R Zabarovsky, S Ingvarsson, G Klein, I Ernberg.   

Abstract

We have examined 17 primary undifferentiated nasopharyngeal carcinoma biopsies for allelic loss on 3p, comparing the findings in tumors with those in normal lymphocyte DNA from the same patients. Ten polymorphic microsatellite markers were used between 3p13 and 3p26. Allelic loss was observed in 12 samples (70%). Two loci were most frequently affected: D3S1067 (3p21.1-14.3) in 60% and D3S1217 (3p14.2-14.1) in 58%. One tumor seemed to have a homozygous deletion at 3p26, detected by the D3S1297 marker. Analysis of the clinical data showed that an increased number of aberrations in 3p was correlated with more advanced tumor stages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913729     DOI: 10.1002/(SICI)1098-2264(199610)17:2<118::AID-GCC7>3.0.CO;2-8

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3.

Authors:  Y Cheng; N E Poulos; M L Lung; G Hampton; B Ou; M I Lerman; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

2.  Identification of novel tumor suppressor genes down-regulated in recurrent nasopharyngeal cancer by DNA microarray.

Authors:  Zhenxiao Huang; Wenfeng Li; Sen Lin; Xiaobi Fang; Chunhong Zhang; Zhisu Liao
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-04

Review 3.  The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both.

Authors:  Edmund Ui-Hang Sim; Choon-Weng Lee; Kumaran Narayanan
Journal:  Biomark Res       Date:  2021-06-30

4.  STGC3 inhibits xenograft tumor growth of nasopharyngeal carcinoma cells by altering the expression of proteins associated with apoptosis.

Authors:  Qing-Chao Qiu; Bo Hu; Xiu-Pei He; Qiao Luo; Guo-Hua Tang; Zhi-Feng Long; Zhu-Chu Chen; Xiu-Sheng He
Journal:  Genet Mol Biol       Date:  2012-02-02       Impact factor: 1.771

5.  Elevated expression of thyroid hormone receptor alpha 2 (c-erb A- alpha 2) in nasopharyngeal carcinoma.

Authors:  J W Lee; C L Chen; B T Juang; J Y Chen; C S Yang; S L Doong
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

6.  Tumor suppressor BLU promotes TRAIL-induced apoptosis by downregulating NF-κB signaling in nasopharyngeal carcinoma.

Authors:  Jiahui Zhou; Zunnan Huang; Ziyou Wang; Shumin Liu; Alf Grandien; Ingemar Ernberg; Zhiwei He; Xiangning Zhang
Journal:  Oncotarget       Date:  2017-07-04

7.  Oxidative stress-induced chromosome breaks within the ABL gene: a model for chromosome rearrangement in nasopharyngeal carcinoma.

Authors:  Sang-Nee Tan; Sai-Peng Sim; Alan Soo-Beng Khoo
Journal:  Hum Genomics       Date:  2018-06-18       Impact factor: 4.639

8.  BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways.

Authors:  Cong Peng; Hua Ying Liu; Ming Zhou; Li Ming Zhang; Xiao Ling Li; Shou Rong Shen; Gui Yuan Li
Journal:  Mol Cell Biochem       Date:  2007-04-26       Impact factor: 3.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.